Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28316001
DOI
10.1007/s11033-017-4100-9
PII: 10.1007/s11033-017-4100-9
Knihovny.cz E-zdroje
- Klíčová slova
- Alzheimer’s disease, Gestational diabetes mellitus, Glucose metabolism, Impaired glucose tolerance, Polymorphisms, Type 2 diabetes mellitus,
- MeSH
- adaptorové proteiny signální transdukční krev genetika MeSH
- alely MeSH
- Alzheimerova nemoc komplikace genetika MeSH
- běloši genetika MeSH
- diabetes mellitus 2. typu genetika MeSH
- dospělí MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci MeSH
- genetická variace MeSH
- genetické asociační studie metody MeSH
- gestační diabetes genetika metabolismus MeSH
- jaderné proteiny krev genetika MeSH
- jednonukleotidový polymorfismus genetika MeSH
- klusterin krev genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- monomerní proteiny vytvářející klathrin krev genetika MeSH
- nádorové supresorové proteiny krev genetika MeSH
- odds ratio MeSH
- porucha glukózové tolerance genetika metabolismus MeSH
- receptory komplementu 3b krev genetika MeSH
- rizikové faktory MeSH
- senioři MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- adaptorové proteiny signální transdukční MeSH
- BIN1 protein, human MeSH Prohlížeč
- CLU protein, human MeSH Prohlížeč
- CR1 protein, human MeSH Prohlížeč
- jaderné proteiny MeSH
- klusterin MeSH
- monomerní proteiny vytvářející klathrin MeSH
- nádorové supresorové proteiny MeSH
- PICALM protein, human MeSH Prohlížeč
- receptory komplementu 3b MeSH
Alzheimer's disease (AD) is the most common type of dementia, with a prevalence that is rising every year. AD is associated with type 2 diabetes mellitus (T2DM) and insulin resistance, and is therefore sometimes called "type 3 diabetes mellitus". The aim of this study was to examine whether the variants of some candidate genes involved in the development of AD, namely BIN1 (rs744373), CLU (rs11136000), CR1 (rs3818361), and PICALM (rs3851179), are related to several disorders of glucose metabolism-gestational diabetes (GDM), T2DM and impaired glucose tolerance (IGT). Our study included 550 women with former GDM and 717 control women, 392 patients with T2DM and 180 non-diabetic controls, and 117 patients with IGT and 630 controls with normal glucose tolerance. Genotyping analysis was performed using specially-designed TaqMan assays. No significant associations of the genetic variants rs744373 in BIN1, rs11136000 in CLU, or rs3818361 in CR1 were found with GDM, T2DM or IGT, but rs3851179 in PICALM was associated with an increased risk of GDM. The frequency of the AD risk-associated C allele was significantly higher in the GDM group compared to controls: OR 1.21; 95% CI (1.03-1.44). This finding was not apparent in T2DM and IGT; conversely, the C allele of the PICALM SNP was protective for IGT: OR 0.67; 95% CI (0.51-0.89). This study demonstrates an association between PICALM rs3851179 and GDM as well as IGT. However, elucidation of the possible role of this gene in the pathogenesis of GDM requires further independent studies.
3rd Faculty of Medicine Charles University Prague Prague Czech Republic
Faculty of Humanities Charles University Prague Prague Czech Republic
Zobrazit více v PubMed
Arch Neurol. 2008 Mar;65(3):329-34 PubMed
Transl Psychiatry. 2012 May 15;2:e117 PubMed
PLoS One. 2015 Jun 15;10(6):e0129776 PubMed
Int J Biochem Cell Biol. 2009 Jun;41(6):1261-8 PubMed
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33 PubMed
J Alzheimers Dis. 2005 Feb;7(1):63-80 PubMed
J Alzheimers Dis. 2005 Dec;8(3):247-68 PubMed
Nat Genet. 2009 Oct;41(10):1088-93 PubMed
Nat Rev Neurosci. 2007 Sep;8(9):663-72 PubMed
Neurobiol Aging. 2014 Apr;35(4):777-85 PubMed
J Nat Sci Biol Med. 2013 Jul;4(2):302-5 PubMed
Int J Environ Res Public Health. 2016 Jul 28;13(8):null PubMed
Nat Genet. 2009 Oct;41(10):1094-9 PubMed
JAMA. 2010 May 12;303(18):1832-40 PubMed
J Alzheimers Dis. 2005 Feb;7(1):45-61 PubMed
Arch Med Res. 2012 Nov;43(8):622-31 PubMed
Alzheimers Dement (Amst). 2015 Dec;1(4):395-402 PubMed
Diabet Med. 2016 Sep;33(9):1211-21 PubMed
PLoS One. 2012;7(8):e44252 PubMed